Rebecca Lim to head up WorldEvents’ Asian expansion
December 24, 2009Business Services Rebecca Lim, WorldEvents, appointment, business services
Rebecca Lim has been appointed by WorldEvents to lead its new Hong Kong office. She is an event professional with …
Promising new drugs could bypass UK approval process
December 23, 2009Sales and Marketing MHRA, MISG, hta, market access
UK patients could next year be given access to drugs that are still in the later stages of clinical development, …
Pharma mergers and acquisitions in 2009
December 22, 2009Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review
This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
PDS appoints Paul Butler and Martin Slade
December 22, 2009Manufacturing and Production PDS, Pharmaceutical Development Services, appointment, manufacturing and production
Pharmaceutical Development Services Ltd (PDS) has expanded its API (Active Pharmaceutical Ingredient) auditing capability, appointing two new associates. Paul Butler …
US health reform heads for decisive vote
December 22, 2009Sales and Marketing Obama, Senate, US healthcare
The US Senate has passed new healthcare legislation, giving President Barack Obama signs of progress on reform in both parliamentary …
Contract research news in brief
December 22, 2009Research and Development AAIPharma, Benten BioServices, CRO, Covance, ICON, PharmaVigilant, Phase Forward, SynRG
Our round-up of developments in the contract research sector includes updates from ICON, SynRG, AAIPharma, Covance, Benten BioServices, Phase Forward …
Sanofi pulls out of Dagenham
December 21, 2009Manufacturing and Production Essex, Sanofi, closure
The UK stands to lose one of its flagship pharmaceutical manufacturing facilities with the recent announcement that Sanofi-Aventis’ site in …
Sanofi’s Plavix combination recommended for European approval
December 21, 2009Research and Development, Sales and Marketing DuoPlavin, Plavix, Sanofi, cabazitaxel, eplivanserin, idrabiotaparinux
Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …
Digital Pharma: Roche tackles sidewiki
December 21, 2009Medical Communications Roche, digi, digital pharma, google, sidewiki
Roche has become the second pharma company to tackle sidewiki on its corporate website, posting an entry that sets out …
Dr Michael Rosenblatt appointed chief medical officer Merck
December 21, 2009Research and Development, Sales and Marketing Dr Michael Rosenblatt, Merck & Co, appointment, appointments, research and development, sales and marketing
Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …
Merck buys Avecia to boost biomanufacturing
December 21, 2009Manufacturing and Production, Research and Development Avecia Biologics, Cobra, Merck & Co, Recipharm
Merck & Co has bolstered its capabilities in biologics production with the acquisition of contract manufacturer Avecia Biologics. The deal …
Time-sensitive shipments go further
December 18, 2009Manufacturing and Production
The logistical challenges of transporting clinical trials samples over long distances arerapidly being overcome, says Sue Lee, Manager of Biopharm …
Chiltern Announces Collaboration with Dr Nawab Qizilbash
December 18, 2009Research and Development
Dr Nawab Qizilbash, MBChB BSc MRCP (UK) MSc Phil (Oxon) is the Director of OXON Epidemiology Ltd. He served as …
Boehringer’s ovarian cancer drug enters phase III
December 18, 2009Research and Development, Sales and Marketing Boehringer, Cancer, ovarian
Boehringer Ingelheim has started a new phase III trial for its investigational cancer drug BIBF 1120. The LUME-Ovar-1 programme will …
UK supports stem cell research with online toolkit
December 18, 2009Research and Development ReNeuron, regenerative medicine, stell cell
A new online resource has been launched to help stem cell researchers in the UK plan a regulatory route for …
Sir Liam Donaldson steps down as England’s chief medical officer
December 18, 2009Liam Donaldson, NHS, UK, appointment
England’s chief medical officer Sir Liam Donaldson will step down in May 2010 after 12 years of service. Details for …
ScopeMedical boosts digital offering
December 18, 2009Medical Communications ScopeMedical, digi
Kent-based med ed agency ScopeMedical has boosted its in-house digital offering and says there are plans to grow it further …
Hospira buys Orchid generic injectables business for $400m
December 18, 2009Manufacturing and Production Hospira, India, Orchid, injectables
Indian active pharmaceutical ingredient manufacturer Orchid Chemicals & Pharmaceuticals has signed a $400 million deal to sell the assets of …
NICE still saying ‘no’ to Roche’s RoActemra
December 17, 2009Sales and Marketing NICE, RoActemra, Roche
Roche will have to present a stronger case for arthritis drug RoActemra in order to gain approval, according to NICE. …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
